StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medivation's (MDVN) Board Split Over Support for Gilead (GILD), Pfizer (PFE) Proposals - Source
May 25, 2016 10:00 AM
Medivation (Nasdaq: MDVN), the target of a hostile bid from French drug maker Sanofi (NYSE: SNY), has received a competing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hot M&A
Mergers and Acquisitions
Rumors
Next Articles
AstraZeneca's (AZN) Phase III FALCON Trial of Fulvestrant vs. Anastrozole Met Primary Endpoint
May 27, 2016 7:08 AM